April 13, 2021
This message was shared for the 2020-21 school year.
A message to our school community partners sent on behalf of Pennsylvania's Acting Secretary of Health, Alison Beam:
I am writing to let you know that the
Pennsylvania Department of Health (DOH) notified all COVID-19 vaccine providers today to pause administering doses of the Johnson & Johnson (Janssen) vaccine until at least April 20 following a recommendation, made out of an abundance of caution, from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA).
According to the CDC and FDA, of the 6.8 million Americans who received the Johnson & Johnson's (Janssen) vaccine, there are six cases (<.00009%) of a rare blood clot in women between the ages of 18 and 48.
If members of your community received the Johnson & Johnson (Janssen) vaccine within the last few weeks and have any health concerns, or if they develop severe headaches, abdominal pain, leg pain, or shortness of breath within three weeks of getting the Johnson & Johnson (Janssen) vaccine, they should contact their health care provider.
Individuals who have appointments scheduled to receive a Pfizer or Moderna COVID-19 vaccination should keep those appointments.
The DOH is closely monitoring this situation and will provide additional information as it becomes available from the CDC and FDA.
Alison Beam, Acting Secretary of the Pennsylvania Department of Health